Stocks · Health care · Pharmaceutical Preparations

Corbus Pharmaceuticals Holdings, Inc.

CRBP Clue Score27
United States Fiscal year ends December CIK 0001595097 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Nishant C Saxena
11 Aug 2026
Chief Business Officer
Buy
2,600
$9.63
$25.04K
Nishant C Saxena
3 Jun 2026
Chief Business Officer
Buy
9,000
$7.58
$68.22K
Nishant C Saxena
2 Jun 2026
Chief Business Officer
Buy
4,500
$7.33
$33.00K
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
25,769
$22.23
$572.79K
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
47,564
$21.47
$1.02M
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
139,551
$20.42
$2.85M
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
66,088
$19.61
$1.30M
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
25,943
$18.36
$476.31K
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
45,085
$17.48
$787.86K
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
8,862
$45.96
$407.30K
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
156,597
$45.26
$7.09M
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
61,668
$44.62
$2.75M
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
18,548
$43.26
$802.39K
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
24,983
$42.25
$1.06M
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
29,342
$41.23
$1.21M
Cormorant Asset Management, LP
7 Mar 2024
10% owner
Buy indirect
102,140
$41.23
$4.21M
Cormorant Asset Management, LP
7 Mar 2024
10% owner
Buy indirect
90,325
$39.99
$3.61M
Cormorant Asset Management, LP
7 Mar 2024
10% owner
Buy indirect
10,736
$39.13
$420.10K
Cormorant Asset Management, LP
7 Mar 2024
10% owner
Buy indirect
46,799
$37.82
$1.77M
Cormorant Asset Management, LP
2 Feb 2024
10% owner
Buy indirect
750,000
$19.00
$14.25M
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
3,200
$38.49
$123.17K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
43,754
$37.49
$1.64M
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
16,484
$36.53
$602.16K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
32,295
$35.83
$1.16M
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
31,549
$34.62
$1.09M
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
18,055
$33.71
$608.63K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
3,866
$32.47
$125.53K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
4,125
$31.86
$131.42K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
2,654
$31.00
$82.27K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
29,244
$29.42
$860.36K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
31,028
$28.82
$894.23K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
36,747
$27.70
$1.02M
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
15,243
$26.66
$406.38K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
14,388
$25.73
$370.20K
Sean F. Moran
10 Aug 2022
Chief Financial Officer
Buy
20,000
$0.26
$5.20K
Yuval Cohen
10 Aug 2022
Chief Executive Officer
Buy
3,800
$0.26
$1.00K
Craig Stuart Millian
10 Aug 2022
Chief Operating Officer
Buy
5,000
$0.25
$1.27K
Yuval Cohen
16 May 2022
Chief Executive Officer
Buy
10,500
$0.25
$2.63K
Sean F. Moran
16 May 2022
Chief Financial Officer
Buy
12,000
$0.30
$3.60K
Sean F. Moran
10 Mar 2022
Chief Financial Officer
Buy
15,000
$0.37
$5.55K
Craig Stuart Millian
10 Mar 2022
Chief Operating Officer
Buy
10,000
$0.37
$3.70K
Yuval Cohen
9 Mar 2022
Chief Executive Officer
Buy
8,600
$0.37
$3.18K
Yuval Cohen
11 Nov 2020
Chief Executive Officer
Buy
4,240
$1.21
$5.13K
Yuval Cohen
17 Mar 2020
Chief Executive Officer
Buy
4,300
$3.49
$15.01K
Barbara White
17 Mar 2020
Chief Medical Officer
Buy
15,606
$3.63
$56.65K
Robert Paul Discordia
17 Mar 2020
Chief Operating Officer
Buy
2,840
$3.54
$10.05K
Craig Stuart Millian
17 Mar 2020
Chief Commercial Officer
Buy
2,000
$4.25
$8.50K
Yuval Cohen
12 Nov 2019
Chief Executive Officer
Buy
1,430
$4.26
$6.09K
Barbara White
12 Nov 2019
Chief Medical Officer
Buy
3,424
$4.38
$14.99K
Robert Paul Discordia
11 Nov 2019
Chief Operating Officer
Buy
2,500
$4.62
$11.56K
Craig Stuart Millian
11 Nov 2019
Chief Commercial Officer
Buy
1,000
$4.38
$4.38K
Craig Stuart Millian
15 Aug 2019
Chief Commercial Officer
Buy
1,500
$5.48
$8.21K
Robert Paul Discordia
12 Aug 2019
Chief Operating Officer
Buy
15,000
$5.86
$87.89K
Yuval Cohen
12 Aug 2019
Chief Executive Officer
Buy
1,175
$6.06
$7.12K
Craig Stuart Millian
12 Aug 2019
Chief Commercial Officer
Buy
1,500
$6.00
$9.00K
Barbara White
12 Aug 2019
Chief Medical Officer
Buy
1,639
$6.10
$10.00K
Barbara White
17 May 2019
Chief Medical Officer
Buy
1,389
$7.20
$10.00K
Sean F. Moran
14 May 2019
Chief Financial Officer
Buy
100
$7.12
$712.00
Craig Stuart Millian
14 May 2019
Chief Commercial Officer
Buy
1,000
$7.23
$7.23K
Yuval Cohen
13 May 2019
Chief Executive Officer
Buy
995
$6.99
$6.95K
John Kenneth Jenkins
15 Mar 2019
Director
Buy
1,000
$6.98
$6.98K
David P Hochman
15 Mar 2019
Director
Buy indirect
2,000
$6.98
$13.96K
Yuval Cohen
14 Mar 2019
Chief Executive Officer
Buy
1,530
$6.49
$9.93K
Sean F. Moran
14 Mar 2019
Chief Financial Officer
Buy
1,500
$6.67
$10.01K
Barbara White
14 Mar 2019
Chief Medical Officer
Buy
4,638
$6.47
$29.99K
Craig Stuart Millian
14 Mar 2019
Chief Commercial Officer
Buy
5,000
$6.85
$34.26K
Sean F. Moran
15 May 2018
Chief Financial Officer
Buy
4,000
$5.77
$23.08K
Yuval Cohen
15 May 2018
Chief Executive Officer
Buy
1,725
$5.85
$10.09K
Barbara White
15 May 2018
Chief Medical Officer
Buy
2,586
$5.87
$15.17K
David P Hochman
14 May 2018
Director
Buy indirect
5,000
$5.48
$27.38K
Sean F. Moran
14 Mar 2018
Chief Financial Officer
Buy
3,100
$6.60
$20.46K
Yuval Cohen
14 Mar 2018
Chief Executive Officer
Buy
1,160
$6.89
$7.99K
Barbara White
14 Mar 2018
Chief Medical Officer
Buy
2,885
$6.89
$19.88K
David P Hochman
14 Mar 2018
Director
Buy indirect
5,000
$6.67
$33.33K
Paris Panayiotopoulos
16 Nov 2017
Director
Buy
14,285
$7.03
$100.39K
David P Hochman
15 Nov 2017
Director
Buy indirect
5,000
$6.55
$32.75K
Yuval Cohen
10 Nov 2017
Chief Executive Officer
Buy
1,000
$7.17
$7.17K
David P Hochman
10 Nov 2017
Director
Buy
10,000
$7.08
$70.80K
Barbara White
10 Nov 2017
Chief Medical Officer
Buy
2,836
$7.00
$19.85K
Sean F. Moran
10 Nov 2017
Chief Financial Officer
Buy
1,500
$7.04
$10.56K
Sean F. Moran
11 Aug 2017
Chief Financial Officer
Buy
2,500
$5.91
$14.78K
Yuval Cohen
11 Aug 2017
Chief Executive Officer
Buy
1,695
$6.00
$10.17K
Barbara White
11 Aug 2017
Chief Medical Officer
Buy
2,479
$6.05
$15.00K
Yuval Cohen
11 May 2017
Chief Executive Officer
Buy
3,250
$6.01
$19.54K
Barbara White
11 May 2017
Chief Medical Officer
Buy
2,435
$6.12
$14.90K
Avery W Catlin
11 May 2017
Director
Buy
5,000
$6.15
$30.74K
David P Hochman
11 May 2017
Director
Buy
3,400
$6.18
$21.01K
Alan F Holmer
11 May 2017
Director
Buy
500
$6.23
$3.12K
Sean F. Moran
11 May 2017
Chief Financial Officer
Buy
3,300
$6.14
$20.26K
Barbara White
17 Mar 2017
Chief Medical Officer
Buy
4,233
$9.49
$40.17K
Sean F. Moran
13 Mar 2017
Chief Financial Officer
Buy
2,000
$9.60
$19.20K
Sean F. Moran
2 Dec 2016
Chief Financial Officer
Buy
1,500
$7.20
$10.80K
Avery W Catlin
22 Nov 2016
Director
Buy
2,000
$7.55
$15.10K
Alan F Holmer
22 Nov 2016
Director
Buy
1,000
$7.49
$7.49K
Yuval Cohen
22 Nov 2016
Chief Executive Officer
Buy
1,340
$7.64
$10.24K
Barbara White
22 Nov 2016
Chief Medical Officer
Buy
1,000
$7.75
$7.75K
David P Hochman
18 Nov 2016
Director
Buy
10,000
$7.00
$69.96K

What was left out

Form 4 filings counted 216
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 19
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 1,398,906
History held since 26 Nov 2014